Status:
UNKNOWN
An Observational Study on Intermittent Self Catheterisation Discontinuation Factors in Multiple Sclerosis Patients
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
French Association for Research on Multiple Sclerosis
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Brief Summary
Urinary disorders (UD) are common in Multiple Sclerosis (MS) and can necessitate using Intermittent Self Catheterisation (ISC). It is well experienced by patients, has little impact on daily life and ...
Detailed Description
Urinary disorders (UD) are common in Multiple Sclerosis (MS). About 65% of patients suffering from moderate to severe troubles. In case of voiding dysfunction, the reference treatment is based on inte...
Eligibility Criteria
Inclusion
- Patient aged 18 to 65 years
- Patient with MS
- First ISC prescription
- Patient giving informed consent
- Patient affiliated to the social security system
Exclusion
- Patient who has already tried / practiced ISC
- Patient under safeguard of justice / guardianship / tutorship
- Pregnant or lactating woman
Key Trial Info
Start Date :
June 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04132037
Start Date
June 26 2019
End Date
December 1 2022
Last Update
October 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHToulouse
Toulouse, France, 31059